[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355247-105":59,"doc-detail-355247-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","paclitaxel-drives-trem2-macrophage-expansion-underlying-its-inferior-therapeutic-efficacy-compared-to-nab-paclitaxel","Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel","","Paclitaxel and nab-paclitaxel show different therapeutic effects and distinct impacts on the tumor immune microenvironment, yet their underlying molecular mechanisms remain insufficiently defined. A meta-analysis indicates nab-paclitaxel achieves higher overall response rates and pathological complete responses than paclitaxel in female breast cancer patients. Mechanistically, paclitaxel—but not nab-paclitaxel—raises macrophage TREM2 expression, expands TREM2+ macrophages, and promotes lung metastasis by activating an ATF3-FGF2 and EGR1-TREM2-EMT signaling axis. Genetic or pharmacologic Trem2 suppression limits paclitaxel-driven lung metastasis in vivo, suggesting TREM2 targeting could enhance efficacy while reducing metastasis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/paclitaxel-drives-trem2-macrophage-expansion-underlying-its-inferior-therapeutic-efficacy-compared-to-nab-paclitaxel/355247/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/paclitaxel-drives-trem2-macrophage-expansion-underlying-its-inferior-therapeutic-efficacy-compared-to-nab-paclitaxel/355247.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does paclitaxel therapeutic efficacy compare with nab-paclitaxel in breast cancer?","Question",{"text":112,"@type":113},"Meta-analysis results show that nab-paclitaxel yields a higher overall response rate and a higher pathological complete response than paclitaxel in female breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does TREM2+ macrophage expansion play in paclitaxel-associated metastasis?",{"text":117,"@type":113},"Paclitaxel increases TREM2 expression in macrophages, expands TREM2+ macrophages, and promotes lung metastasis in female mouse breast cancer models, linking TREM2-driven myeloid changes to metastatic progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanisms and interventions suppress paclitaxel-induced lung metastasis?",{"text":121,"@type":113},"Paclitaxel enhances the ATF3-FGF2 axis in breast cancer cells, leading to activation of the EGR1-TREM2-EMT cytokine axis in macrophages. Genetic deletion of Trem2 or pharmacologic targeting using antisense oligonucleotides suppresses paclitaxel-induced lung metastasis in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355247,1790573067,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","| |  |  | |\n| --- | --- | --- | --- |\n| Article [https://doi.org/10.1038/s41467-026-69060-5](https://doi.org/10.1038/s41467-026-69060-5) |  |  |  |\n| Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efﬁcacy compared to Nab-paclitaxel |  |  |  |\n| Received: 20 June 2025\u003Cbr>Accepted: 26 January 2026 Check for updates | Yuqi Xing1,2,3, Ruiqi Zhong 4,5, Qianchen Li1,2,3, Xinwei Duan1,2,3, Moyang Xu4,5, Miao Yu1,2,3, Chenying Liu6, Junming He1,2,3, Yi Sun1,2,3, Yunling Wang7, Xiaojing Guo6 , Yunfei Xu 8 , Hongnan Mo 4,5 , Fei Ma 4,5 , Hongquan Zhang 1,2,3,9  & Jun Zhan 1,2,3 \u003Cbr>Paclitaxel and nab-paclitaxel differ in therapeutic efﬁcacy and modulation of the tumor immune microenvironment, yet the molecular basis remains poorly deﬁned. Here, based on a meta-analysis, we ﬁrst show that treatment with nabpaclitaxel results in a higher overall response rate and pathological complete response compared to paclitaxel in female patients with breast cancer. Notably, TREM2 expression in macrophages is elevated in primary tumors of paclitaxel-but not nab-paclitaxel-treated female patients. In metastatic breast cancer, TREM2+ macrophage inﬁltration is increased in primary tumors. In breast cancer models in female mice, paclitaxel, but not nab-paclitaxel, promotes lung metastasis by recruiting TREM2+ macrophages to primary tumors. Mechanistically, paclitaxel enhances the ATF3-FGF2 axis in breast cancer cells; secreted FGF2 activates the EGR1-TREM2-EMT cytokine axis in macrophages. Genetic ablation of Trem2 or pharmacologic targeting with antisense oligonucleotides suppress paclitaxel-induced breast cancer lung metastasis in vivo. Collectively, our ﬁndings demonstrate that paclitaxel, but not nab-paclitaxel, stimulates TREM2 expression and expands TREM2+ macrophages, suggesting that TREM2 targeting could enhance paclitaxel efﬁcacy while limiting metastasis. |  |  |\n| Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-related mortality among women worldwide1,2. Taxanes, including paclitaxel (PTX) and nab-paclitaxel (Nab-PTX), remain ﬁrst-line chemotherapeutic agents, with Nab-PTX comprising |  | PTX bound to albumin nanoparticles3,4. By exploiting the endogenous albumin transport pathway, Nab-PTX enhances tumor-speciﬁc drug delivery, increasing intratumoral drug concentration and potentiating antitumor effects5. Nab-PTX demonstrates efﬁcacy even in patients |  |\n\n1School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China. 2Peking University International Cancer Institute, Peking University Health Science Center, Beijing, China. 3State Key Laboratory of Molecular Oncology, Peking University Health Science Center, Beijing, China. 4Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 5State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 6Department of Breast Cancer Pathology and Research Laboratory, Tianjin Medical University Cancer Institute & Hospital, Tianjin, China. 7Institute of Cardiovascular Research, Peking University Health Science Center, Beijing, China. 8Department of General Surgery, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. 9Tianfu Jincheng Laboratory (Frontier Medical Center), Chengdu, Sichuan, China. e-mail: [guoxiaojing@tjmuch.com](guoxiaojing@tjmuch.com); [xuyunfei1988@126.com](xuyunfei1988@126.com);  \n[mhnzlyynk@outlook.com](mhnzlyynk@outlook.com); [drmafei@126.com](drmafei@126.com); [Hongquan.Zhang@bjmu.edu.cn](Hongquan.Zhang@bjmu.edu.cn); [Zhanjun@bjmu.edu.cn](Zhanjun@bjmu.edu.cn)  \nwith disease progression following prior PTX therapy6,7. However, the comparative clinical b","cbCaiuS4YAeEr145","https://ap.wps.com/l/cbCaiuS4YAeEr145","pdf",13819232,18,"English","# Background\n## Paclitaxel vs nab-paclitaxel clinical and immunologic differences\n## Role of TREM2 in tumor immunity\n# Study Rationale\n## Hypothesis on TREM2 mediating paclitaxel poor efficacy\n# Key Findings\n## Nab-paclitaxel outperforms paclitaxel in meta-analysis outcomes\n## Paclitaxel elevates TREM2 expression and drives TREM2+ macrophage expansion\n## Mechanistic pathway and EMT cytokine axis in macrophages\n## Trem2 genetic ablation or antisense targeting suppresses metastasis\n# Implications\n## TREM2 targeting to enhance paclitaxel efficacy and limit metastasis","[{\"question\":\"How does paclitaxel therapeutic efficacy compare with nab-paclitaxel in breast cancer?\",\"answer\":\"Meta-analysis results show that nab-paclitaxel yields a higher overall response rate and a higher pathological complete response than paclitaxel in female breast cancer patients.\"},{\"question\":\"What role does TREM2+ macrophage expansion play in paclitaxel-associated metastasis?\",\"answer\":\"Paclitaxel increases TREM2 expression in macrophages, expands TREM2+ macrophages, and promotes lung metastasis in female mouse breast cancer models, linking TREM2-driven myeloid changes to metastatic progression.\"},{\"question\":\"What mechanisms and interventions suppress paclitaxel-induced lung metastasis?\",\"answer\":\"Paclitaxel enhances the ATF3-FGF2 axis in breast cancer cells, leading to activation of the EGR1-TREM2-EMT cytokine axis in macrophages. Genetic deletion of Trem2 or pharmacologic targeting using antisense oligonucleotides suppresses paclitaxel-induced lung metastasis in vivo.\"}]","Paclitaxel drives TREM2+ macrophage expansion underlying its inferior therapeutic efficacy compared to Nab-paclitaxel | PDF",1790117056,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/262087d6ec5196c34ceed090658803e6.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc214debdafe8c5c43b276e46c180419.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d21d12bd6197353c2b1c6feb27ba43de.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c48534476fb2fa01408c3e985bf6511b.webp",980,1301]